| Product NDC: | 43857-0111 |
| Proprietary Name: | Coxsackie |
| Non Proprietary Name: | Coxsackie B1, B4 |
| Active Ingredient(s): | 200; 200 [hp_C]/mL; [hp_C]/mL & nbsp; Coxsackie B1, B4 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43857-0111 |
| Labeler Name: | BioActive Nutritional, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20121009 |
| Package NDC: | 43857-0111-1 |
| Package Description: | 30 mL in 1 BOTTLE, DROPPER (43857-0111-1) |
| NDC Code | 43857-0111-1 |
| Proprietary Name | Coxsackie |
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43857-0111-1) |
| Product NDC | 43857-0111 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Coxsackie B1, B4 |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20121009 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | BioActive Nutritional, Inc. |
| Substance Name | HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4 |
| Strength Number | 200; 200 |
| Strength Unit | [hp_C]/mL; [hp_C]/mL |
| Pharmaceutical Classes |